Cox Bryan F.'s Form 4 filing
TriSalus Life Sciences, Inc. (TLSI) · filed Dec 19, 2024
- Accession no.
- 0001415889-24-029909
- Filed
- Dec 19, 2024
- Trade date
- Oct 5, 2024
- Filing delay
- 75 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.39K. It was filed 75 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cox Bryan F.CIK 0001981787 | Officer (CHIEF SCIENTIFIC & MANUFACT.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2024 | Common Stock | SSaleDisposed | −314 | $4.44 | −$1,394.16 | 86,382 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.